West Pharmaceutical Servs shares are trading higher after Barclays upgraded the stock from Equal-Weight to Overweight rating and raised its price target from $310 to $400.

Benzinga Newsdesk www.benzinga.com Positive 95.1%

Neg 0% Neu 0% Pos 95.1%

Comments

No comments yet. Be the first!